drugset / Trial / NCT02207491
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the ocular hypotensive efficacy and ocular and systemic safety of AR-13324 Ophthalmic Solution, 0.02% compared to the active comparator Timolol maleate Ophthalmic Solution, 0.5%
Timeline
- Start
- 2014-07
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Netarsudil | Small molecule | 0.02 % | Topical |
| Comparator | Timolol | Other / unclassified | 0.5 % | Topical |